Filter Results:
(2,361)
Show Results For
- All HBS Web
(5,035)
- People (16)
- News (1,907)
- Research (2,361)
- Events (2)
- Multimedia (222)
- Faculty Publications (1,875)
Show Results For
- All HBS Web
(5,035)
- People (16)
- News (1,907)
- Research (2,361)
- Events (2)
- Multimedia (222)
- Faculty Publications (1,875)
Sort by
- 03 Jul 2012
- First Look
First Look: July 3
Klinik: Eating Disorder Care Michael E. Porter, Emma Stanton, Jessica A. Hohman, and Caleb StowellHarvard Business School Case 712-475 The Schön Klinik is a private, for-profit German hospital group trying to establish itself as a premium... View Details
Keywords: Sean Silverthorne
- May 2023 (Revised June 2023)
- Supplement
Novartis (C): Reimagining Medicine
By: Ramon Casadesus-Masanell, Claudio Feser, Karolin Frankenberger and David Redaschi
This case unfolds around the first-ever approved personalized cancer treatment, how Novartis wrapped it into a new business model design, and how Novartis scaled it. Novartis — one of the largest pharmaceutical companies in the world — is, among other ventures,... View Details
Keywords: Health Testing and Trials; Health Care and Treatment; Business Model; Problems and Challenges; Pharmaceutical Industry; Switzerland
Casadesus-Masanell, Ramon, Claudio Feser, Karolin Frankenberger, and David Redaschi. "Novartis (C): Reimagining Medicine." Harvard Business School Supplement 723-445, May 2023. (Revised June 2023.)
- Winter 2022
- Article
Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities
By: Eric Budish, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast and Andrew A. Torkelson
By January 2022, the COVAX international vaccine collaboration had allocated over a billion vaccines to over 140 countries. We describe and review the allocation process chosen, which reflected both an objective of equitably distributing vaccines across the world and... View Details
Keywords: Vaccines; Pandemics; Health Care and Treatment; Health Pandemics; Distribution; Supply Chain; Equality and Inequality
Budish, Eric, Hannah Kettler, Scott Duke Kominers, Erik Osland, Canice Prendergast, and Andrew A. Torkelson. "Distributing a Billion Vaccines: COVAX Successes, Challenges, and Opportunities." Oxford Review of Economic Policy 38, no. 4 (Winter 2022): 941–974.
- 2011
- Working Paper
Individual Rationality and Participation in Large Scale, Multi-Hospital Kidney Exchange
By: Itai Ashlagi and Alvin E. Roth
As multi-hospital kidney exchange clearinghouses have grown, the set of players has grown from patients and surgeons to include hospitals. Hospitals have the option of enrolling only their hard-to-match patient-donor pairs, while conducting easily arranged exchanges... View Details
Keywords: Health Care and Treatment; Resource Allocation; Market Participation; Marketplace Matching; Organizations; Networks; Motivation and Incentives; Health Industry
Ashlagi, Itai, and Alvin E. Roth. "Individual Rationality and Participation in Large Scale, Multi-Hospital Kidney Exchange." NBER Working Paper Series, No. 16720, January 2011.
- September 2002 (Revised April 2006)
- Case
Istituto Clinico Humanitas (A)
By: Richard M.J. Bohmer, Gary P. Pisano and Ning Tang
Istituto Clinico Humanitas is a newly built private hospital, south of Milan, Italy, that has attained unusual profitability while treating public system patients. The hospital was built and is managed by Techosp, a subsidiary of Techint, a global engineering and... View Details
Keywords: Health Care and Treatment; Management Analysis, Tools, and Techniques; Management Systems; Infrastructure; Managerial Roles; Integration; Performance; Health Industry; Milan
Bohmer, Richard M.J., Gary P. Pisano, and Ning Tang. "Istituto Clinico Humanitas (A)." Harvard Business School Case 603-063, September 2002. (Revised April 2006.)
- May 2025
- Teaching Note
The VideaHealth AI Factory: CEO Florian Hillen on Speed, Scale, and Innovation
By: Tsedal Neeley
Teaching Note for HBS Case No. 425-720. Florian Hillen, co-founder and CEO of VideaHealth, a startup using artificial intelligence (AI) to detect dental conditions on x-rays, spent the early years of his company laying the groundwork for an AI factory. This AI factory,... View Details
- 15 Aug 2005
- HBS Case
Classic Cases Live On at HBS
quality service, attention to patients, and an attractive work environment for doctors and staff—must be taken into account. By showing the positive impact of making health care more consumer-oriented,... View Details
Keywords: by Garry Emmons
- May 4, 2023
- Article
Falling Insulin Prices—What Just Happened?
By: Leemore S. Dafny
Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details
Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry
Dafny, Leemore S. "Falling Insulin Prices—What Just Happened?" New England Journal of Medicine 388, no. 18 (May 4, 2023): 1636–1639.
- 2024
- Working Paper
Fecal Microbiota Transplants —Too Simple to be Safe? Case Histories of Transformational Advances
By: Amar Bhide and Srikant M. Datar
By 2013, after many decades of very slow development and adoption, Fecal Microbiota Transplantation procedures were attracting widespread attention. This case history chronicles the: 1) pioneering fecal transplants performed in the 20th century; 2) development of the... View Details
Keywords: Health Care and Treatment; Innovation and Invention; Governing Rules, Regulations, and Reforms
Bhide, Amar, and Srikant M. Datar. "Fecal Microbiota Transplants —Too Simple to be Safe? Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 21-132, June 2021. (Revised May 2024.)
- Article
Time-Driven Activity-Based Costing in Emergency Medicine
By: Robert S. Kaplan, Brian J. Yun, Anand M. Prabhakar, Jonathan Warsh, John Brennan, Kyle E. Dempsey and Ali S. Raja
Value in emergency medicine is determined by both patient-important outcomes and the costs associated with achieving them. However, measuring true costs is challenging. Without an understanding of costs, emergency department (ED) leaders will be unable to determine... View Details
Keywords: Time-Driven Activity-Based Costing; Emergency Room; Health Care and Treatment; Value; Cost Management; Activity Based Costing and Management
Kaplan, Robert S., Brian J. Yun, Anand M. Prabhakar, Jonathan Warsh, John Brennan, Kyle E. Dempsey, and Ali S. Raja. "Time-Driven Activity-Based Costing in Emergency Medicine." Annals of Emergency Medicine 67, no. 6 (June 2016): 765–772.
- Summer 2021
- Article
Predictable Country-level Bias in the Reporting of COVID-19 Deaths
By: Botir Kobilov, Ethan Rouen and George Serafeim
We examine whether a country’s management of the COVID-19 pandemic relate to the downward biasing of the number of reported deaths from COVID-19. Using deviations from historical averages of the total number of monthly deaths within a country, we find that the... View Details
Keywords: COVID-19; Deaths; Reporting; Incentives; Government Policy; Health Pandemics; Health Care and Treatment; Country; Crisis Management; Outcome or Result; Reports; Policy
Kobilov, Botir, Ethan Rouen, and George Serafeim. "Predictable Country-level Bias in the Reporting of COVID-19 Deaths." Journal of Government and Economics 2 (Summer 2021).
- November 2005 (Revised December 2006)
- Case
Jeanette Clough at Mount Auburn Hospital
Jeanette Clough, the CEO of Mt. Auburn Hospital, successfully leads a turnaround for the struggling local hospital. When she assumed leadership of Mt. Auburn in 1998, the hospital had recently suffered a $10 million loss. During her first six months, several members of... View Details
Keywords: Organizational Change and Adaptation; Change Management; Leading Change; Expansion; Health Care and Treatment; Business and Community Relations; Health Industry; Cambridge
Roberts, Laura Morgan, and Ayesha Kanji. "Jeanette Clough at Mount Auburn Hospital." Harvard Business School Case 406-068, November 2005. (Revised December 2006.)
- 04 Oct 2016
- First Look
October 4, 2016
https://cb.hbsp.harvard.edu/cbmp/product/217007-PDF-ENG Harvard Business School Case 816-066 Mohamed Azab and Seha Capital In January 2011, Mohamed Azab, founder and CEO of health care investment firm Seha... View Details
- June 2024
- Supplement
Legacy Partners (A)
By: Richard S. Ruback and Royce Yudkoff
Instructors should consider the timing of making videos available to students, as they may reveal key case details.
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Stephen Holbrook and Austin Pulsipher (both HBS '19) had been leading Nutrishare since acquiring the company six months earlier in mid-2021.... View Details
Keywords: Acquisition; Small Business; Cost vs Benefits; Decisions; Corporate Entrepreneurship; Leadership Style; Leading Change; Business or Company Management; Problems and Challenges; Health Care and Treatment; Health Disorders; Medical Specialties; Nutrition; Supply Chain Management; Growth Management; Health Industry; Health Industry; Health Industry; United States; California
Ruback, Richard S., and Royce Yudkoff. "Legacy Partners (A)." Harvard Business School Multimedia/Video Supplement 224-725, June 2024.
- 09 Sep 2014
- First Look
First Look: September 9
assessing the startup health care company's 2014 marketing plan. On December 31, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology that, when added to... View Details
Keywords: Sean Silverthorne
- September 2011
- Teaching Note
Tengion: Bringing Regenerative Medicine to Life (TN)
By: Elie Ofek and Natalie Kindred
Teaching Note for 510031. View Details
- 19 Jun 2012
- First Look
First Look: June 19
312-002 McKesson, a large, diversified drug distribution and health care IT company, is considering development of new business offerings to help private practice physicians remain independent. The company,... View Details
Keywords: Sean Silverthorne
- November 2009 (Revised August 2010)
- Case
NovoCure Ltd.
By: William A. Sahlman and Sarah Flaherty
Venture capitalist William Doyle must raise $35 million for a portfolio company with a promising, novel cancer therapy, just as global capital markets are imploding in the fall of 2008. NovoCure, Ltd., has developed an electrical-field-based therapy, called Tumor... View Details
Keywords: Financial Crisis; Entrepreneurship; Venture Capital; Investment; Health Care and Treatment; Health Testing and Trials; Technological Innovation; Financial Services Industry
Sahlman, William A., and Sarah Flaherty. "NovoCure Ltd." Harvard Business School Case 810-045, November 2009. (Revised August 2010.)
- 31 May 2016
- First Look
May 31, 2016
June 2016 Medical Care Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination Clinics By: Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn I. Reynolds... View Details
Keywords: Sean Silverthorne
- 20 Jun 2017
- First Look
First Look at New Research and Ideas, June 20
School Case 317-103 PharmAccess and the M-TIBA Platform: Leveraging Digital Technology in the Developing World PharmAccess is an Amsterdam-based NGO working to support the development of the private health View Details
Keywords: Sean Silverthorne